Entry Detail



General Information

Database ID:exR0226508
RNA Name:hsa-miR-320c
RNA Type:miRNA
Chromosome:chr18
Starnd:+
Coordinate:
Start Site(bp):24321716End Site(bp):24321735
External Links:hsa-miR-320c



Disease Information

Disease Name:Latent Tuberculosis
Disease Category:Infections
MeSH ID:D055985
Type:Diseases Category/Infections
Alias:Latent Tuberculoses//Tuberculoses, Latent//Tuberculosis, Latent//Latent Tuberculosis Infection//Infection, Latent Tuberculosis//Infections, Latent Tuberculosis//Latent Tuberculosis Infections//Tuberculosis Infection, Latent//Tuberculosis Infections, Latent



Expression Detail

GEO ID:GSE124120
Description:Small RNA Profiles of Serum Exosomes Derived from Individuals with Latent and Active Tuberculosis
Experimental Design:Disease vs Control
Case Disease Type:Active Tuberculosis
Case Disease SubType:NA
Case Sample:Latent Tuberculosis
Control Sample:Healthy
Number of Case:1
Number of Control:1
Number of Samples:2





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ACAP2
chr3
195274745
195443044
-
ASB1
chr2
238426742
238452250
+
BLCAP
chr20
37492472
37527931
-
CGN
chr1
151510510
151538692
+
CKAP5
chr11
46743048
46846308
-
FJX1
chr11
35618460
35620865
+
GMCL1
chr2
69829660
69881384
+
GNAI2
chr3
50226292
50259362
+
HAS3
chr16
69105653
69118719
+
MIER3
chr5
56919602
56971675
-
PFN1
chr17
4945652
4949061
-
SIN3A
chr15
75369379
75455842
-
SRSF7
chr2
38743599
38751494
-
TRIM14
chr9
98069275
98119222
-
ZCCHC2
chr18
62523025
62587709
+
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000417
chr12
69644908
69656342
+
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0000095
chr1
95609446
95616975
+
hsa_circ_0000744
chr17
15968183
15971435
-
hsa_circ_0000652
chr15
90984737
90986710
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC002044.1
chr16
73014319
73014476
-
AC016876.2
chr17
7581964
7584086
-
AC092718.4
chr16
81030770
81031485
+
AL022311.1
chr22
37876148
37895563
+
AL162258.1
chr1
153626332
153634340
-
DLEU1
chr13
50082169
50906856
+
GAS5
chr1
173858559
173868882
-
LINC00641
chr14
21200079
21206900
-
MALAT1
chr11
65497688
65506516
+
MIR3142HG
chr5
160438594
160487426
+
NEAT1
chr11
65422774
65445540
+
NR2F2-AS1
chr15
96110040
96327361
-
OIP5-AS1
chr15
41283990
41309737
+
SNHG1
chr11
62851984
62855953
-
SNHG12
chr1
28578538
28583132
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE124120
Sample Source:Blood
Source Fraction:Exosome
Platform:GPL16791
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:356
Sample treatment protocol:We first performed differential centrifugation (1000 g for 10 min at 4 °C, and 16,500 g for 30 min at 4 °C) to remove the cell debris, followed by ultrafiltration using 0.22 um filters. We then performed ultracentrifugation (120,000 g for 2 hours) to obtain exosome pellets. Transmission electron microscopy (TEM) was employed to visualize exosomes. The exosome pellets were first suspended and dropped onto 200 mesh copper grids, followed by incubation in 3% phosphotungstic acid for 10 min. The copper mesh was then washed three times with water and dried for observation by TEM. We also analyzed the exosome size distributions using the nanoparticle tracking analysis (NTA, Malvern, UK) according to the manufacturer's instructions.
RNA Extract protocol:NA
RNA library preparation protocol:Small RNA libraries were prepared for sequencing using standard Illumina protocols.



Reference

PMID:https://doi.org/10.3389/fmicb.2019.01174
Title:Small RNA Profiles of Serum Exosomes Derived From Individuals With Latent and Active Tuberculosis
Author:Lingna Lyu, Xiuli Zhang, Cuidan Li, Tingting Yang, Jinghui Wang, Liping Pan, Hongyan Jia, Zihui Li, Qi Sun, Liya Yue, Fei Chen and Zongde Zhang
Journal:Front. Microbiol., 28 May 2019 | https://doi.org/10.3389/fmicb.2019.01174
Description:In this study, we performed small RNA sequencing to explore small RNA profiles of serum exosomes derived from LTBI and TB patients and healthy controls (HC).